All Curated Mutation Sites in HSV2 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HSV2 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
TK
  
DNA pol
  
UL52
  
UL5
  
UL30
  
UL23
  

Keyword: UL5
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 27056950 A1001G
UL5
UL5
HSV-2 Infection
R
S
View
2 27056950 A739T
UL5
UL5
HSV-2 Infection
R
S
View
3 27056950 C1281T
UL5
UL5
HSV-2 Infection
R
S
View
4 27056950 C996T
UL5
UL5
HSV-2 Infection
R
S
View
5 27056950 D513N
UL5
UL5
HSV-2 Infection
R
S
View
6 27056950 G879A
UL5
UL5
HSV-2 Infection
R
S
View
7 27056950 H334R
UL5
UL5
HSV-2 Infection
R
S
View
8 27056950 I763V
UL5
UL5
HSV-2 Infection
R
S
View
9 27056950 R415H
UL5
UL5
HSV-2 Infection
R
S
View
10 27056950 S458G
UL5
UL5
HSV-2 Infection
R
S
View
11 27056950 S605P
UL5
UL5
HSV-2 Infection
R
S
View
12 27056950 S689T
UL5
UL5
HSV-2 Infection
R
S
View
13 27056950 T1965G
UL5
UL5
HSV-2 Infection
R
S
View
14 27056950 T2100C
UL5
UL5
HSV-2 Infection
R
S
View
15 27056950 Y573H
UL5
UL5
HSV-2 Infection
R
S
View
16 27056950 G1053A
UL5
UL5
HSV-2 Infection
R
S
View
17 22687623 K355N
UL5
UL5
Cell line
D
View
18 22687623 K451R
UL5
UL5
Cell line
D
View
Contents
Description

The table shows all curated mutation sites of HSV2 in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.